Paolo Tarantino/X
Feb 19, 2025, 13:58
Paolo Tarantino: 8 ADC breast cancer trials expected to reshape practice in 2025
Paolo Tarantino, Advanced research fellow at Dana-Farber Cancer Institute, shared a post on X:
“2025 is anticipated to be the year with the highest number of phase 3 ADC trials read outs in breast oncology, with impact for all breast cancer subtypes.
Here’s 8 ADC breast cancer trials expected to reshape practice in 2025.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 10, 2025, 15:01
May 10, 2025, 15:01
May 10, 2025, 14:14
May 10, 2025, 14:11
May 10, 2025, 13:57